Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-126
Closed -$9.39K 1013
2025
Q4
$9.39K Buy
126
+119
+1,700% +$8.7K ﹤0.01% 606
2025
Q3
$473 Hold
7
﹤0.01% 1386
2025
Q2
$457 Buy
+7
New +$420 ﹤0.01% 1345
2023
Q4
Sell
-34
Closed -$2.36K 439
2023
Q3
$2.36K Buy
+34
New +$2.57K ﹤0.01% 408

Other funds holding HOLX

Clearstead Trust's HOLX Position: Q1 2026 in Review

Clearstead Trust sold out of Hologic (HOLX) in Q1 2026, closing a stake of 126 shares — an estimated $9.39K sold.

Clearstead Trust first reported a position in HOLX in Q3 2023 and held it in 4 quarters. The position peaked at $9.39K in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Clearstead Trust reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Clearstead Trust sold 126 Hologic shares in Q1 2026, an estimated $9.39K.
  • Clearstead Trust first reported a position in Hologic in Q3 2023 and held it in 4 quarters.
  • Clearstead Trust's Hologic position peaked at $9.39K in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.